Antirna Incorporated

Developing antiviral agents for treating COVID-19 patients, this discovery will stimulate the opening of a new avenue in therapeutics directed at the SARS virus

  • Stage Concept Only
  • Industry Biotechnology
  • Location Burlington, MA, USA
  • Currency USD
  • Founded June 2020
  • Employees 2
  • Incorporation Type C-corp
  • Website antirna.com

Company Summary

Developing antiviral agents relevant to the public health because novel coronavirus SARS-CoV-2, the causative agent of COVID-19 respiratory disease. Our product are potent antiviral agents interacting by inhibition of SAH hydrolase inhibitors in treating COVID-19 patients, this discovery will stimulate the opening of a new avenue in therapeutics directed at the COVID-19 virus.

Team

Advisors

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free